The way towards tailored treatment for metastatic renal cancer patients in the omics era: are we getting a “transcriptomic compass”?

類似資料

• The interplay between cholesterol (and other metabolic conditions) and immune-checkpoint immunotherapy: shifting the concept from the “inflamed tumor” to the “inflamed patient”
  著者:: Bersanelli, Melissa, 等
  出版事項: (2021)
• Role of stereotactic body radiation therapy for the management of renal cell carcinoma: tailoring treatment in the era of the “embarrassment of riches”
  著者:: Buti, Sebastiano, 等
  出版事項: (2019)
• Family history of cancer and DNA damage response genes: Two sides of the same coin?
  著者:: Cortellini, Alessio, 等
  出版事項: (2018)
• Cabozantinib in metastatic renal cell carcinoma: latest findings and clinical potential
  著者:: Bersanelli, Melissa, 等
  出版事項: (2017)
• Everolimus in the management of metastatic renal cell carcinoma: an evidence-based review of its place in therapy
  著者:: Buti, Sebastiano, 等
  出版事項: (2016)